Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salvianolic acid B
- Development stage
- Preclinical
- Lead developer
- Nanjing Hongqiao Pharmaceutical Technology Research Institute
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous
01
Overview
Salvianolic acid B is a water-soluble polyphenolic compound and major active constituent of Salvia miltiorrhiza (Danshen). It has potent antioxidant, anti-inflammatory, cardioprotective, neuroprotective, antineoplastic, hepatoprotective, and metabolism-regulating effects. Its mechanisms are mainly associated with free radical scavenging, anti-inflammatory effects, inhibition of apoptosis and fibrosis, and modulation of various cellular signaling pathways, including suppression of NF-κB and TLR4/NLRP3 inflammasome pathways. Salvianolic acid B has been widely used in traditional Chinese medicine, including as an injectable formulation studied in clinical trials for its safety and pharmacokinetics[1][2][3][4][7].
- Other names
- lithospermic acid Bdanfensuan Bdan shen suan Bsalvianolate b121521-90-2
02
Targets
TLR4 (Toll-like receptor 4)CASP1 (Caspase-1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on salvianolic acid B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salvianolic acid B.